12/31/17

Financial Statements

Current Assets 355,540.74

Total Assets 570,689.00

Net Sales 1,514,371.18

Operating Exp. (excluding COGS, interest &FIT) 305,152.65

Net Income 128,719.60

Net cash provided by operating activities 57,345.50

Net increase in cash 82,279.10

Accounts Receivable Aged T/B

Current Accounts Receivable 27,044.00

Yearend Worksheet

12/31/17 Unadjusted Trial Balance Total 2,096,292.41

Adjustments Column Total 1,245,661.79

Journals

Sales Journal credit to #30100 53,601.00

Purchases Journal debit to #30500 49,659.00

Cash Receipts Journal debit to #10100 102,697.36

Cash Disbursements Journal credit to #10100 70,833.88

Payroll Journal debit to #40500 14,570.69

General Ledger Balances

#30100 Sales (preclosing) 1,590,883.00

#30400 Cost of Goods Sold (preclosing) 1,026,379.96

1) Through December 22, how many transactions have you recorded in the General Journal and what was it (were they) for?

___________________